Description
-
- RUZURGI is a potassium channel blocker indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 to less than 17 years of age.
How to use:
-
- Patients 6 to less than 17 years of age weighing 45 kg or more:
-
- Initial dosage is 15 mg to 30 mg daily, in pided doses
-
- Increase daily in 5 mg to 10 mg increments, pided in up to 5 doses daily
-
- Maximum single dose is 30 mg; maximum daily dosage is 100 mg
-
- Patients 6 to less than 17 years of age weighing 45 kg or more:
Caution & Warnings:
-
- History of seizures
-
- Hypersensitivity to amifampridine or other aminopyridine
Side Effects:
-
- Paresthesia/dysesthesia, abdominal pain, dyspepsia, dizziness, and nausea.
Ingredients:
- Amifampridine 10Mg.






Reviews
There are no reviews yet.